Who
Jeffrey Thomas Elliott
Director
Company insider
Files Form 4 as: Director, Quanterix; Director, Icon; Director, Sera Prognostics; Chief Financial Officer, Exact Sciences; Director, Exagen.
In numbers
- Trades disclosed
- 161
- Buys
- 0
- Sells
- 34
- Bought
- $0
- Sold
- $31.0M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 1 May 2017
- Last trade
- 19 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 20 Aug 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —3,955 | filing |
| 19 Aug 2026filed 20 Aug 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,955 at $0.00 | filing |
| 19 Aug 2026filed 20 Aug 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,955 at $0.00 | filing |
| 19 Aug 2026filed 20 Aug 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code M | —3,955 | filing |
| 10 Aug 2026filed 11 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 2 Jan 2026filed 14 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 2 Jan 2026filed 14 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 20 Mar 2025filed 21 Mar 2025 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —47,363 at $0.00 | filing |
| 20 Mar 2025filed 21 Mar 2025 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —30,534 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,821 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —7,435 at $0.00 | filing |
| 19 Aug 2024filed 21 Aug 2024 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,908 at $0.00 | filing |
| 19 Aug 2024filed 21 Aug 2024 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —11,985 at $0.00 | filing |
| 1 May 2024filed 2 May 2024 | Exact Sciences | SEC FORM 4 Sold | $8,180136 at $60.15 | filing |
| 30 Apr 2024filed 2 May 2024 | Exact Sciences | SEC FORM 4 Code A | —291 at $0.00 | filing |
| 30 Apr 2024filed 2 May 2024 | Exact Sciences | SEC FORM 4 Code A | $21K707 at $30.02 | filing |
| 1 Mar 2024filed 4 Mar 2024 | Exact Sciences | SEC FORM 4 Sold | $143K2,412 at $59.32 | filing |
| 29 Feb 2024filed 4 Mar 2024 | Exact Sciencesoption or derivative | SEC FORM 4 Code M | —5,291 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | Exact Sciences | SEC FORM 4 Code M | —5,291 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.